Menu
Recruiting NCT07427108

Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety

No phase Interventional Peripheral Arterial Disease Vascular Diseases

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Road-map guided versus US guided retrograde access.
Who it may be relevant to
Registry conditions: Peripheral Arterial Disease, Vascular Diseases. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The study aims to compare the technical feasibility and safety of road mapping-guided versus ultrasound-guided retrograde arterial puncture in patients with (CLTI) as measured by: * Puncture success rate * Access-related complication rate (e.g., hematoma, vessel dissection, perforation)

Interventions

  • Procedure Road-map guided versus US guided retrograde access
    Road-map guided versus US guided retrograde access

Primary outcome measures

  • Success rate [Time frame: 12 months]
  • Complication rate [Time frame: 12 months]

Eligibility criteria

Inclusion criteria: -.

  • Adults : Both male and female participants.
  • Diagnosed with critical limp threatening ischemia (CLTI):

significant occlusions in the femoropopliteal

o Rutherford Class 5: Non-healing wounds or ulcers

  • Failed or unable to achieve antegrade access:

Patients requiring retrograde puncture for the procedure.

  • Planned intervention with retrograde access: Candidates for endovascular interventions, including angioplasty, stent deployment

Exclusion criteria

  • Active infection at the puncture site: Any localized infection, particularly over the ankle region , will be an exclusion.
  • Severe calcification or anatomical abnormalities: Patients with excessive arterial calcification or significant anatomical distortion preventing safe retrograde puncture.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Sohag University Hospital — Sohag

Identifiers

NCT: NCT07427108 · Soh-Med-26-1-1MS

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗